- Release Date: 19/03/21 11:37
- Summary: COVID19 Vaccine Feasibility Assessment
- Price Sensitive: Yes
- Download Document 383.14KB
- Forums
- ASX - By Stock
- IDT
- Ann: COVID19 Vaccine Feasibility Assessment
Ann: COVID19 Vaccine Feasibility Assessment
-
- There are more pages in this discussion • 871 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IDT (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
-0.010(8.70%) |
Mkt cap ! $45.13M |
Open | High | Low | Value | Volume |
11.5¢ | 11.5¢ | 10.0¢ | $124.0K | 1.145M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 109533 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 40772 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 109533 | 0.105 |
5 | 172999 | 0.100 |
1 | 30000 | 0.099 |
2 | 211111 | 0.090 |
1 | 125000 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 40772 | 2 |
0.115 | 250000 | 2 |
0.120 | 151064 | 4 |
0.125 | 250000 | 2 |
0.130 | 202341 | 2 |
Last trade - 15.06pm 13/11/2024 (20 minute delay) ? |
Featured News
IDT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online